A citation-based method for searching scientific literature

L Hanus, A Breuer, S Tchilibon, S Shiloah, D Goldenberg, M Horowitz, R G Pertwee, R A Ross, R Mechoulam, E Fride. Proc Natl Acad Sci U S A 1999
Times Cited: 422







List of co-cited articles
1666 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
L A Matsuda, S J Lolait, M J Brownstein, A C Young, T I Bonner. Nature 1990
29

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
S Galiègue, S Mary, J Marchand, D Dussossoy, D Carrière, P Carayon, M Bouaboula, D Shire, G Le Fur, P Casellas. Eur J Biochem 1995
26

Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W A Devane, L Hanus, A Breuer, R G Pertwee, L A Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etinger, R Mechoulam. Science 1992
25

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
R Mechoulam, S Ben-Shabat, L Hanus, M Ligumsky, N E Kaminski, A R Schatz, A Gopher, S Almog, B R Martin, D R Compton. Biochem Pharmacol 1995
21

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
R G Pertwee, A C Howlett, M E Abood, S P H Alexander, V Di Marzo, M R Elphick, P J Greasley, H S Hansen, G Kunos, K Mackie,[...]. Pharmacol Rev 2010
20

Identification and functional characterization of brainstem cannabinoid CB2 receptors.
Marja D Van Sickle, Marnie Duncan, Philip J Kingsley, Abdeslam Mouihate, Paolo Urbani, Ken Mackie, Nephi Stella, Alexandros Makriyannis, Daniele Piomelli, Joseph S Davison,[...]. Science 2005
19

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
A C Howlett, F Barth, T I Bonner, G Cabral, P Casellas, W A Devane, C C Felder, M Herkenham, K Mackie, B R Martin,[...]. Pharmacol Rev 2002
19

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.
Mohab M Ibrahim, Hongfeng Deng, Alexander Zvonok, Debra A Cockayne, Joyce Kwan, Heriberto P Mata, Todd W Vanderah, Josephine Lai, Frank Porreca, Alexandros Makriyannis,[...]. Proc Natl Acad Sci U S A 2003
369
18

CB2 cannabinoid receptor-mediated peripheral antinociception.
Philip T Malan, Mohab M Ibrahim, Hongfeng Deng, Qian Liu, Heriberto P Mata, Todd Vanderah, Frank Porreca, Alexandros Makriyannis. Pain 2001
323
18

CB2: a cannabinoid receptor with an identity crisis.
Brady K Atwood, Ken Mackie. Br J Pharmacol 2010
417
17

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.
Marjolein Soethoudt, Uwe Grether, Jürgen Fingerle, Travis W Grim, Filomena Fezza, Luciano de Petrocellis, Christoph Ullmer, Benno Rothenhäusler, Camille Perret, Noortje van Gils,[...]. Nat Commun 2017
191
17

Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Sangdon Han, Jayant Thatte, Daniel J Buzard, Robert M Jones. J Med Chem 2013
89
17


2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
T Sugiura, S Kondo, A Sukagawa, S Nakane, A Shinoda, K Itoh, A Yamashita, K Waku. Biochem Biophys Res Commun 1995
16

Peripheral cannabinoid receptor, CB2, regulates bone mass.
Orr Ofek, Meliha Karsak, Nathalie Leclerc, Meirav Fogel, Baruch Frenkel, Karen Wright, Joseph Tam, Malka Attar-Namdar, Vardit Kram, Esther Shohami,[...]. Proc Natl Acad Sci U S A 2006
378
15

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
M Rinaldi-Carmona, F Barth, J Millan, J M Derocq, P Casellas, C Congy, D Oustric, M Sarran, M Bouaboula, B Calandra,[...]. J Pharmacol Exp Ther 1998
551
15

Endocannabinoid signaling at the periphery: 50 years after THC.
Mauro Maccarrone, Itai Bab, Tamás Bíró, Guy A Cabral, Sudhansu K Dey, Vincenzo Di Marzo, Justin C Konje, George Kunos, Raphael Mechoulam, Pal Pacher,[...]. Trends Pharmacol Sci 2015
395
15

The endocannabinoid system as an emerging target of pharmacotherapy.
Pál Pacher, Sándor Bátkai, George Kunos. Pharmacol Rev 2006
15

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
R A Ross, H C Brockie, L A Stevenson, V L Murphy, F Templeton, A Makriyannis, R G Pertwee. Br J Pharmacol 1999
328
14


Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.
Kenneth J Valenzano, Laykea Tafesse, Gary Lee, James E Harrison, Jamie M Boulet, Susan L Gottshall, Lilly Mark, Michelle S Pearson, Wendy Miller, Shen Shan,[...]. Neuropharmacology 2005
216
14

3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
J W Huffman, J Liddle, S Yu, M M Aung, M E Abood, J L Wiley, B R Martin. Bioorg Med Chem 1999
233
14

The orphan receptor GPR55 is a novel cannabinoid receptor.
E Ryberg, N Larsson, S Sjögren, S Hjorth, N-O Hermansson, J Leonova, T Elebring, K Nilsson, T Drmota, P J Greasley. Br J Pharmacol 2007
14

Beta-caryophyllene is a dietary cannabinoid.
Jürg Gertsch, Marco Leonti, Stefan Raduner, Ildiko Racz, Jian-Zhong Chen, Xiang-Qun Xie, Karl-Heinz Altmann, Meliha Karsak, Andreas Zimmer. Proc Natl Acad Sci U S A 2008
428
14

Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.
Jian-Ping Gong, Emmanuel S Onaivi, Hiroki Ishiguro, Qing-Rong Liu, Patricia A Tagliaferro, Alicia Brusco, George R Uhl. Brain Res 2006
581
13

Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
Yolanda Gómez-Gálvez, Cristina Palomo-Garo, Javier Fernández-Ruiz, Concepción García. Prog Neuropsychopharmacol Biol Psychiatry 2016
111
12

Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma, R L Mitchell. Mol Pharmacol 1995
659
12

The CB2 receptor and its role as a regulator of inflammation.
Caroline Turcotte, Marie-Renée Blanchet, Michel Laviolette, Nicolas Flamand. Cell Mol Life Sci 2016
242
12

Crystal Structure of the Human Cannabinoid Receptor CB2.
Xiaoting Li, Tian Hua, Kiran Vemuri, Jo-Hao Ho, Yiran Wu, Lijie Wu, Petr Popov, Othman Benchama, Nikolai Zvonok, K'ara Locke,[...]. Cell 2019
176
12


Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
Javier Fernández-Ruiz, Julián Romero, Guillermo Velasco, Rosa M Tolón, José A Ramos, Manuel Guzmán. Trends Pharmacol Sci 2007
281
11


Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.
Sabine Steffens, Niels R Veillard, Claire Arnaud, Graziano Pelli, Fabienne Burger, Christian Staub, Meliha Karsak, Andreas Zimmer, Jean-Louis Frossard, François Mach. Nature 2005
336
10


CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency.
Reem Smoum, Saja Baraghithy, Mukesh Chourasia, Aviva Breuer, Naama Mussai, Malka Attar-Namdar, Natalya M Kogan, Bitya Raphael, Daniele Bolognini, Maria G Cascio,[...]. Proc Natl Acad Sci U S A 2015
40
25

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.
Katarzyna Maresz, Erica J Carrier, Eugene D Ponomarev, Cecilia J Hillard, Bonnie N Dittel. J Neurochem 2005
344
10

Early phytocannabinoid chemistry to endocannabinoids and beyond.
Raphael Mechoulam, Lumír O Hanuš, Roger Pertwee, Allyn C Howlett. Nat Rev Neurosci 2014
190
10


CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.
M Beltramo, N Bernardini, R Bertorelli, M Campanella, E Nicolussi, S Fredduzzi, A Reggiani. Eur J Neurosci 2006
223
10

The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects.
Steven G Kinsey, Anu Mahadevan, Bingjun Zhao, Hang Sun, Pattipati S Naidu, Raj K Razdan, Dana E Selley, M Imad Damaj, Aron H Lichtman. Neuropharmacology 2011
72
13


Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures.
Tian Hua, Xiaoting Li, Lijie Wu, Christos Iliopoulos-Tsoutsouvas, Yuxia Wang, Meng Wu, Ling Shen, Christina A Brust, Spyros P Nikas, Feng Song,[...]. Cell 2020
112
10


Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic pain.
Sean P Hollinshead, Michael W Tidwell, John Palmer, Rossella Guidetti, Adam Sanderson, Michael P Johnson, Mark G Chambers, Jennifer Oskins, Robert Stratford, Peter C Astles. J Med Chem 2013
28
32

Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.
M Bouaboula, C Poinot-Chazel, J Marchand, X Canat, B Bourrié, M Rinaldi-Carmona, B Calandra, G Le Fur, P Casellas. Eur J Biochem 1996
226
9

Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis.
J T Toguri, C Lehmann, R B Laprairie, A M Szczesniak, J Zhou, E M Denovan-Wright, M E M Kelly. Br J Pharmacol 2014
54
16


Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.
B F Cravatt, D K Giang, S P Mayfield, D L Boger, R A Lerner, N B Gilula. Nature 1996
9

The endocannabinoid system and its therapeutic exploitation.
Vincenzo Di Marzo, Maurizio Bifulco, Luciano De Petrocellis. Nat Rev Drug Discov 2004
725
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.